通过观察哮喘大鼠肺组织病理学改变、测定支气管肺泡灌洗液（BALF）细胞总数、淋巴细胞（Ly）、嗜酸性粒细胞（Eos）、中性粒细胞（Neu）的百分比以及肺组织和BALF中的转化生长因子-β1（TGF-β1），以探讨神香草总黄酮对哮喘大鼠气道炎症的影响，阐明维药神香草总黄酮抗哮喘的部分作用机制。试验中将大鼠随机分为正常对照组、哮喘模型组、氨茶碱阳性对照组、神香草总黄酮高、中、低剂量治疗组。采用卵清白蛋白（OVA）、氢氧化铝及百白破疫苗联合致敏和OVA生理盐水雾化激发的方法制备哮喘模型。测定BALF中细胞总数、Ly、Eos、Neu的百分比；采用酶联免疫吸附试验（ELISA）法检测肺组织及BALF中TGF-β1水平。结果显示，与模型组相比，各治疗组中，大鼠BALF中细胞总数、Ly、Eos、Neu的百分比、TGF-β1水平及肺组织中的TGF-β1水平均明显下降，差异有统计学意义（P<0.05）；神香草总黄酮各剂量组之间相互比较，BALF及肺组织中的以上指标差异均有统计学意义（P<0.05），呈剂量依赖性趋势。由此推测，维药神香草总黄酮可能通过抑制Ly、Eos、Neu等炎症细胞及细胞因子TGF-β1的分泌，减轻或改善哮喘的气道炎症。
The effect of the Uygur medicine Hyssopus officinalis L. total flavonoids on pathological changes in the lung tissue of asthmatic rats is observed and the total number of cells and the percentage of lymphocytes (Ly), eosinophils (Eos), neutrophils (Neu) in BALF, the level of TGF-β1 in BALF and the lung tissue are studied for the mechanism of its treatment of asthma. The rats were randomly divided into the normal control group, the asthma model group, the aminophylline treatment group, the Hyssopus total flavonoids groups of high, medium and low dose treatments. They were sensitized with OVA, Al(OH)3 and DPT vaccine and then were challenged with the inhalation of aerosolized OVA solution for preparation of the asthma model. The level of the lung tissue and BALF TGF-β1 were determined with ELISA, the total number of cells and the percentage of Ly, Eos, Neu in BALF were determined by light microscope. The results show that as compared with the asthma model group, the level of TGF-β1, the total number of cells and the percentage of Ly, Eos, Neu in BALF and the level of the lung tissue TGF-β1 were significantly lower in those of treated groups (P<0.05); among different dose treatment groups, the level of TGF-β1, the total number of cells and the percentage of Ly, Eos, Neu in BALF and the level of the lung tissue TGF-β1 were significantly reduced (P<0.05) with a dose-dependent trend in alleviating the airway inflammation of the asthma., Hyssopus officinalis L. total flavonoids may inhibit the secretion of TGF-β1, Ly, Eos, Neu, reducing the airway inflammation of the asthma.
[1] 郭振武, 李明飞. 中医药治疗支气管哮喘作用机理的实验研究进展[J]. 辽宁中医杂志, 2008, 35(7): 1116-1117. Guo Zhenwu, Li Mingfei. Liaoning Journal of Traditional Chinese Medicine, 2008, 35(7): 1116-1117.
[2] Garcia G, Godot V, Hnmhert M, et al. New chemokine targets for asthma therapy[J]. Current allergy asllergy and Asthma Reports, 2005, 5(2): 155-160.
[3] 国家中医药管理局《中华本草》编委会. 中华本草: 维吾尔药卷[M]. 上海: 上海科学技术出版社, 2005. State Administration of Traditional Chinese Herbal Editorial Board. The Chinese materia medica: Uyghur medicine volume[M]. Shanghai: Publishing House of Shanghai Science and Technology, 2005.
[4] 中华人民共和国卫生部药典委员会. 中华人民共和国卫生部药品标准: 维吾尔药分册[M]. 乌鲁木齐: 新疆科技卫生出版社, 1999. Ministry of Health Pharmacopoeia Committees. Drug standard of ministry of public health of the people's republic of China: Uyghur medicine branch[M]. Urumqi: Publishing House of Xinjiang Science and Technology, 1999.
[5] 麦合苏木·艾克木, 努尔江·肉孜, 阿不都热依木·玉苏甫. 维药神香草乙酸乙酯部位对大鼠实验性哮喘炎症反应的影响[J]. 科技导报, 2011, 29(30): 52-56. Ekim Mahsum, Rozi Nurjan, Yusup Abdiryim. Science & Technology Review, 2011, 29(30): 52-56.
[6] 阿不都热依木·玉苏甫, 哈木拉提·吾甫尔, 麦合苏木·艾克木, 等. 一种神香草总黄酮提取物及其制备方法和用途: 中国, 201210399112.X[P]. 2013-03-13. Abdiryim Yusup, Halmurat Upur, Mahsum Hakim, et al. Preparation method and use of total flavonoids of Hyssopus cuspidatus Boriss. or Hyssopus officinalis L.[P]. China Patent, 201210399112.X. 2013-03-13.
[7] 曾南, 杨旋, 周祯昊, 等. 荆芥挥发油对哮喘模型小鼠肺组织炎症介质的影响[J]. 四川生理科学杂志, 2006, 28(4): 154-156. Zeng Nan, Yang Xuan, Zhou Zhenhao, et al. Sichuan Journal of Physiological Sciences, 2006, 28(4): 154-156.
[8] 王亚男, 马骏, 马秀敏, 等. 维吾尔药神香草对变应性哮喘小鼠细胞因子的影响[J]. 上海中医药大学学报, 2008, 22(3): 58-60. Wang Yanan, Ma Jun, Ma Xiumin, et al. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai, 2008, 22(3): 58-60.
[9] Fong C Y, Pang L, Holland E, et a1. TGF-beta 1 stimulates IL-8 release, COX-2 expression, and PGE(2) release inhuman airway muscle cells[J]. AJP-Lung Cellular and Molecular Physiology, 2000, 279(1): 1201-I207.
[10] Kariyawasam H H, Aizen M, Barkans J, et al. Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma[J]. American Journal of Respiratory and Critical Care Medicine, 2007, 175: 896-904.
[11] 戴欢, 张维溪, 贺孝良, 等. 黄芪在哮喘大鼠气道重塑模型中对TGF-β-/Smads 信号通路的调控[J]. 中华中医药学刊, 2010, 28(12): 2494-2498. Dai Huan, Zhang Weixi, He Xiaoliang, et al. Chinese Archives of Traditional Chinese Medicine, 2010, 28(12): 2494-2498.
[12] 黎友伦, 罗永艾. 氨茶碱的药理作用与临床应用[J]. 医药导报, 2005 (9): 807-809. Li Youlun, Luo Yongai. Herald of Medicine, 2005(9): 807-809.
